People channel feed – Endpoints News

People channel feed

Takeda to lay off more employees in Massachusetts

10 months ago

Aerovate plans to lay off nearly all employees after trial failure

10 months ago

Q&A: Vertex’s pain research chief on moving beyond opioids, AI and how pharma acquisitions thrive or fail

11 months ago

Ginkgo to cut at least 35% of staff in multi-year restructuring plan

11 months ago

Biopharma leaders charting a path for the industry's LGBTQ+ community

11 months ago

Lilly cracks down further on compounded tirzepatide as GLP-1 shortage starts to ease

11 months ago

Stephen Squinto talks writing checks and next-gen obesity drugs as JP Morgan closes first $500M+ biotech fund

11 months ago

Bill Haney gives up CEO post at Skyhawk, becomes chairman; Bayer parts ways with head of biotech

11 months ago

Barinthus Bio to lay off 25% of its workforce and focus on just two programs

11 months ago

Corrected: Life science company Agilent cuts over 180+ employees in California

11 months ago

Teladoc names insurance executive as new CEO

11 months ago

Google's parent company Alphabet poaches Eli Lilly CFO; More changes at Exscientia

11 months ago

Former Sanofi R&D leader Frank Nestle to lead Deerfield’s growing drug discovery arm

11 months ago

Amarin names new CEO as Patrick Holt departs

11 months ago

BioNTech co-founder Özlem Türeci on ‘hip’ ADCs and the power of combo therapies

11 months ago

Neurocrine CEO Kevin Gorman to retire after 32-year run; Bluebird picks up fifth CFO in three years

11 months ago

Ikena Oncology weighs ‘strategic options’ as it drops cancer asset, trims headcount to save cash

12 months ago

Joe Panetta to step down as Biocom California CEO

12 months ago

Takeda to lay off 640 workers in Massachusetts as part of multiyear overhaul

12 months ago

After 14 years calling partnering shots at Genentech/Roche, James Sabry is headed back into the biotech fray

12 months ago

Idorsia’s Jean-Paul Clozel retires as CEO, plots next steps; CRISPR Therapeutics nabs CMO from Sanofi

Last year

Pfizer announces another $1.5B in cost cuts — and plans for more to come

Last year

AI biotech Exscientia to trim nearly a quarter of workforce, following pipeline cut and CEO firing

Last year

Updated: Lobbying group BIO restructures staff in shakeup under new CEO

Last year

First page Previous page 9 10 111213 14 15 Next page Last page